Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Index by author

December 01, 2016; Volume 13,Issue 4

Guest Editor’s Preface

  • You have access
    Liver cancer: challenge and prospect
    Qiang Li
    Cancer Biology & Medicine December 2016, 13 (4) 405-406; DOI: https://doi.org/10.20892/j.issn.2095-3941.2016.0097

Review

  • You have access
    Role of microRNAs in inflammation-associated liver cancer
    Lin Huan, Lin-Hui Liang and Xiang-Huo He
    Cancer Biology & Medicine December 2016, 13 (4) 407-425; DOI: https://doi.org/10.20892/j.issn.2095-3941.2016.0071
  • You have access
    Portal vein embolization for induction of selective hepatic hypertrophy prior to major hepatectomy: rationale, techniques, outcomes and future directions
    David Li and David C. Madoff
    Cancer Biology & Medicine December 2016, 13 (4) 426-442; DOI: https://doi.org/10.20892/j.issn.2095-3941.2016.0083
  • You have access
    Three-dimensional printing: review of application in medicine and hepatic surgery
    Rui Yao, Gang Xu, Shuang-Shuang Mao, Hua-Yu Yang, Xin-Ting Sang, Wei Sun and Yi-Lei Mao
    Cancer Biology & Medicine December 2016, 13 (4) 443-451; DOI: https://doi.org/10.20892/j.issn.2095-3941.2016.0075
  • You have access
    Portal vein tumor thrombus is a bottleneck in the treatment of hepatocellular carcinoma
    Ju-Xian Sun, Jie Shi, Nan Li, Wei-Xing Guo, Meng-Chao Wu, Wan-Yee Lau and Shu-Qun Cheng
    Cancer Biology & Medicine December 2016, 13 (4) 452-458; DOI: https://doi.org/10.20892/j.issn.2095-3941.2016.0059
  • You have access
    Molecular landscape in acute myeloid leukemia: where do we stand in 2016
    Karam Al-Issa and Aziz Nazha
    Cancer Biology & Medicine December 2016, 13 (4) 474-482; DOI: https://doi.org/10.20892/j.issn.2095-3941.2016.0061
  • You have access
    Human endogenous retroviruses and cancer
    María Gonzalez-Cao, Paola Iduma, Niki Karachaliou, Mariacarmela Santarpia, Julià Blanco and Rafael Rosell
    Cancer Biology & Medicine December 2016, 13 (4) 483-488; DOI: https://doi.org/10.20892/j.issn.2095-3941.2016.0080
  • You have access
    Properties and feasibility of using cancer stem cells in clinical cancer treatment
    Xiao-Mei Gao, Rui Zhang, Qiong-Zhu Dong and Lun-Xiu Qin
    Cancer Biology & Medicine December 2016, 13 (4) 489-495; DOI: https://doi.org/10.20892/j.issn.2095-3941.2016.0076

Original Article

  • You have access
    Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients
    Xiao-Fei Zhang, Xin Yang, Hu-Liang Jia, Wen-Wei Zhu, Lu Lu, Wei Shi, Hao Zhang, Jin-Hong Chen, Yi-Feng Tao, Zheng-Xin Wang, Jun Yang, Lian-Xin Wang, Ming Lu, Yan Zheng, Jing Zhao, Qiong-Zhu Dong and Lun-Xiu Qin
    Cancer Biology & Medicine December 2016, 13 (4) 459-468; DOI: https://doi.org/10.20892/j.issn.2095-3941.2016.0077
  • You have access
    Surgical treatment of intrahepatic cholangiocarcinoma: a retrospective study of 104 cases
    Xiao-Dong Xun and Qiang Li
    Cancer Biology & Medicine December 2016, 13 (4) 469-473; DOI: https://doi.org/10.20892/j.issn.2095-3941.2016.0063
  • You have access
    Ki-67 as a prognostic marker according to breast cancer molecular subtype
    Nahed A. Soliman and Shaimaa M. Yussif
    Cancer Biology & Medicine December 2016, 13 (4) 496-504; DOI: https://doi.org/10.20892/j.issn.2095-3941.2016.0066
  • You have access
    Leptin influences estrogen metabolism and increases DNA adduct formation in breast cancer cells
    Samia Shouman, Mohamed Wagih and Marwa Kamel
    Cancer Biology & Medicine December 2016, 13 (4) 505-513; DOI: https://doi.org/10.20892/j.issn.2095-3941.2016.0079

Case Report

  • You have access
    Work-up and management of a high-risk patient with primary central nervous system lymphoma
    Pervin A. Zeynalova, Gayane S. Tumyan, Mikhail B. Dolgushin and Mobil I. Akhmedov
    Cancer Biology & Medicine December 2016, 13 (4) 514-518; DOI: https://doi.org/10.20892/j.issn.2095-3941.2016.0070
Back to top
PreviousNext

In this issue

Cancer Biology and Medicine: 13 (4)
Cancer Biology & Medicine
Vol. 13, Issue 4
1 Dec 2016
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

Jump to

  • Guest Editor’s Preface
  • Review
  • Original Article
  • Case Report

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire